NEW YORK (GenomeWeb) – DiaSorin and the Tecan Group today announced a collaboration to develop a nucleic acid extraction platform.

Financial and other terms of the deal were not disclosed.

The new platform will leverage Tecan's Fluent Laboratory Automation Solution along with DiaSoriin's Liaison MDX PCR system to provide users a complete sample-to-result system, the firms said, adding the Fluent instrument will be optimized for use with DiaSorin's extraction chemistry and automated PCR technology.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.